Clearside Biomedical
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CLSD and other ETFs, options, and stocks.About CLSD
Clearside Biomedical, Inc. is a biopharmaceutical company, which delivers therapies to the back of the eye through the suprachoroidal space. Its pipeline include CLS-AX, Integrin Inhibitor, and gene therapy.
CEOGeorge M. Lasezkay
CEOGeorge M. Lasezkay
Employees30
Employees30
HeadquartersAlpharetta, Georgia
HeadquartersAlpharetta, Georgia
Founded2011
Founded2011
Employees30
Employees30
CLSD Key Statistics
Market cap98.63M
Market cap98.63M
Price-Earnings ratio-2.60
Price-Earnings ratio-2.60
Dividend yield—
Dividend yield—
Average volume267.50K
Average volume267.50K
High today$1.45
High today$1.45
Low today$1.29
Low today$1.29
Open price$1.44
Open price$1.44
Volume201.25K
Volume201.25K
52 Week high$2.12
52 Week high$2.12
52 Week low$0.6501
52 Week low$0.6501
CLSD News
Simply Wall St 2d
Even after rising 23% this past week, Clearside Biomedical shareholders are still down 55% over the ... - Simply Wall StIt's nice to see the Clearside Biomedical, Inc. ( ) share price up 23% in a week. Meanwhile over the last three years the stock has dropped hard. In that time,...
